Adalimumab biosimilar
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Adalimumab biosimilar, covering 2021-01-12 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis [NA]